Ken Ito
- Molecular Biology
- Oncology top 10%
- Pharmacology top 2%
- Pulmonary and Respiratory Medicine
- Plant Science
- Co-authors
- Takeshi IwatsuboShin‐ichi KanamitsuY SugiyamaYukiko NakajimaDidier DulonHirofumi FujiiYusuke OjiShusei Hamamichi
- Topics
- Cancer, Hypoxia, and Metabolism (7 papers)Renal and related cancers (6 papers)Cancer Cells and Metastasis (4 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Ken Ito
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 499
- Oncology 286
- Pharmacology 208
- Pulmonary and Respiratory Medicine 108
- Plant Science 86
Countries citing papers authored by Ken Ito
This map shows the geographic impact of Ken Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ito more than expected).
Fields of papers citing papers by Ken Ito
This network shows the impact of papers produced by Ken Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ito. The network helps show where Ken Ito may publish in the future.
Co-authorship network of co-authors of Ken Ito
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Ito. A scholar is included among the top collaborators of Ken Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Ito. Ken Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 27 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 49 | |
| 7 | 19 | |
| 8 | 25 | |
| 9 | 57 | |
| 10 | 76 | |
| 11 | 21 | |
| 12 | 39 | |
| 13 | Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers. | 9 |
| 14 | 4 | |
| 15 | 29 | |
| 16 | A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro. | 72 |
| 17 | 8 | |
| 18 | 0 | |
| 19 | 0 | |
| 20 | 1 |
About Ken Ito
Ken Ito is a scholar working on Microbiology, Developmental Biology and Structural Biology, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Renal and related cancers (6 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Pharmacology (208 citations), Oncology (286 citations) and Molecular Biology (499 citations). Ken Ito has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Takeshi Iwatsubo, Shin‐ichi Kanamitsu, Y Sugiyama, Yukiko Nakajima, Didier Dulon, Hirofumi Fujii, Yusuke Oji, Shusei Hamamichi, Yoshitaka Oka and Izumi O. Umeda. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.